Bringing Knowledge About Chronic Kidney Disease in Brazil: Filling the Gap

This is a multicenter cross-sectional study will randomly screen kidney function in adult patients with known risk factors for chronic kidney disease (CKD) within the Brazilian general population. Kidney function will be assessed using a point-of-care creatinine test at local healthcare facilities. Patients with abnormal test results will be referred for laboratory confirmation within three months and will undergo evaluation by the local nephrology team to determine the need for follow-up care.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Renal Insufficiency, Chronic Chronic Disease Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Urogenital Diseases Urologic Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Sociedade Brasileira de Nefrologia

São Paulo, 04044-000, Brazil

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age > 18 years old
At least one risk factor for CKD as mentioned above.

Exclusion criteria

Patients with previous diagnosis of CKD
Patients younger than 18 years old
Patients unable to give informed consent to participate in the study.

Treatment and study plan

Primary outcomes

CKD potential prevalence

Time frame: Through study completation, an avarege 1 year

To estimate the prevalence of Chronic Kidney Disease (CKD) in Brazil through random screening using a portable device for creatinine measurement and eGFR estimation in adult patients with risk factors for the development of CKD across the five regions of the country.

Secondary outcomes

Regional CKD potential prevalence

Time frame: Through study completation, an avarege 1 year

To evaluate regional differences regarding CKD prevalence

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Cross-sectional Study to Evaluate the Chronic Kidney Disease Prevalence Using a Creatinine Point-of-care Tool in Brazilian Adult Patients With Known CKD Risk Factors Randomly Selected

Acronym: Filling gap

Important dates

Study start: 2025
Primary completion: 2025
Study completion: 2025
First posted: Aug 5, 2025
Registry last updated: Oct 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed